Bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors

By  

Medical Oncology, Vol. 24, Iss. 2, 2007-06 ,pp. : 189-196

Humana Press, Inc

Access to resources Recommend Favorite

Combination chemotherapy employing bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors

By Rubenstein Marvin   Tsui Paulus   Guinan Patrick  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 372-378

Humana Press, Inc

Access to resources Recommend Favorite

A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells

By Bühler P.   Wolf P.   Gierschner D.   Schaber I.   Katzenwadel A.   Schultze-Seemann W.   Wetterauer U.   Tacke M.   Swamy M.   Schamel W.   Elsässer-Beile U.  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 1, 2008-01 ,pp. : 43-52

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of prostate and breast tumors employing mono- and bi-specific antisense oligonucleotides targeting apoptosis inhibitory proteins clusterin and bcl-2

By Rubenstein Marvin   Tsui Paulus   Guinan Patrick  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 592-599

Humana Press, Inc

Access to resources Recommend Favorite

Effects of 14 frequently used drugs on prostatespecific antigen expression in prostate cancer LNCaP cells

By                

Oncology Letters, Vol. 7, Iss. 5, 2014-01 ,pp. : 1665-1668

Spandidos Publications

Access to resources Recommend Favorite